Biobot Surgical
Singapore’s Biobot Surgical raises $15M to expand robotic prostate cancer platform into US market
Biobot Surgical, a Singapore-based medical technology company developing robotic-assisted systems for prostate cancer diagnosis and treatment, has secured S$20 million ($15.4 million) in its latest financing round led by ClavystBio in partnership with ZIG Ventures.
June 30, 2026
ADB commits up to $57.5 million to Asia infrastructure fund
November 19, 2026
KJTS secures 20-year cooling deal for Bangkok hospital
November 19, 2026
MAS and ABS set PayNow Gen2 rollout through 2028
November 19, 2026
FOMO Pay taps Anchorage Digital for US stablecoin infrastructure
November 19, 2026
ADB commits up to $57.5 million to Asia infrastructure fund
November 19, 2026
KJTS secures 20-year cooling deal for Bangkok hospital
November 19, 2026
MAS and ABS set PayNow Gen2 rollout through 2028
November 19, 2026
FOMO Pay taps Anchorage Digital for US stablecoin infrastructure
November 19, 2026




